Adamas Pharma (ADMS) Reports Q1 Loss of $1.06/Share

Adamas Pharma (NASDAQ: ADMS) reported Q1 EPS of ($1.06), versus ($1.27) reported last year. Revenue for the quarter came in at $13.3 million, versus $568 thousand reported last year.

For earnings history and earnings-related data on Adamas Pharma (ADMS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c